Jensen Bente Thoft, Hjort Peter Blak, Melchiorsen Kathrine, Thaysen Henriette Vind, Larsen Ida, Lorenzen Mai, Knudsen Rikke, Keller Anna K
Department of Urology, Aarhus University Hospital, 8200 Aarhus, Denmark.
National Center for Research in Cancer Surgery (ACROBATIC), Aarhus University, 8200 Aarhus, Denmark.
Cancers (Basel). 2025 Sep 8;17(17):2939. doi: 10.3390/cancers17172939.
The potential benefits of prehabilitation in patients undergoing surgery for renal cell carcinoma (RCC) or upper-tract urothelial carcinoma (UTUC) remain unknown. The aim was to evaluate physical function and baseline characteristics over the course of treatment to identify a potential need for prehabilitation.
In this prospective observational study, 62 patients were enrolled-31 undergoing nephrectomies for RCC and 31 undergoing nephroureterectomy for UTUC. Baseline assessments included nutritional screening (NRS 2002), frailty (Clinical Frailty Scale), hemoglobin and iron levels, smoking status, and physical function using the Six-Minute Walk Test (6MWT) and the 30-Second Sit-to-Stand Test (30STS). Functional tests were repeated at hospital discharge and at two-week postoperative follow-up visit.
At baseline, 45% of RCC and 68% of UTUC patients were at nutritional risk. Preoperative frailty was present in 20% of the cohort, and 53% had anemia. Functional impairment below the lower limit values (LLVs) was observed in 16% for the RCC and 36% of the UTUC, assessed by 6MWT. The 30 STS revealed that 58% of RCC and 42% of UTUC were below LLV. At discharge, impairment peaked, with 59% and 82% of patients being below the LLVs, respectively. Functional performance partially recovered at follow-up but did not return to baseline levels.
Preoperative nutritional deficits, anemia, and functional impairment are prevalent in patients undergoing nephrectomy or nephroureterectomy. A marked postoperative functional decline was identified postoperatively supporting a potential need for early individualized prehabilitation strategies to improve recovery in patients undergoing kidney cancer surgery.
术前康复对接受肾细胞癌(RCC)或上尿路尿路上皮癌(UTUC)手术患者的潜在益处尚不清楚。目的是评估治疗过程中的身体功能和基线特征,以确定术前康复的潜在需求。
在这项前瞻性观察研究中,纳入了62例患者——31例行肾切除术治疗RCC,31例行肾输尿管切除术治疗UTUC。基线评估包括营养筛查(NRS 2002)、衰弱(临床衰弱量表)、血红蛋白和铁水平、吸烟状况,以及使用六分钟步行试验(6MWT)和30秒坐立试验(30STS)评估身体功能。在出院时和术后两周随访时重复进行功能测试。
基线时,45%的RCC患者和68%的UTUC患者存在营养风险。术前衰弱在20%的队列中存在,53%的患者有贫血。通过6MWT评估,RCC患者中16%和UTUC患者中36%的功能损害低于下限值(LLV)。30 STS显示,58%的RCC患者和42%的UTUC患者低于LLV。出院时,损害达到峰值,分别有59%和82%的患者低于LLV。随访时功能表现部分恢复,但未恢复到基线水平。
接受肾切除术或肾输尿管切除术的患者术前存在营养缺乏、贫血和功能损害。术后发现明显的功能下降,支持可能需要早期个体化的术前康复策略,以改善肾癌手术患者的恢复情况。